Sanjay Ahuja Appointed CEO and Medical Director of Innovative Hematology
Sanjay Ahuja, Chief Medical Officer, CEO and Medical Director of Innovative Hematology, Inc., shared Innovative Hematology, Inc.‘s post on LinkedIn:
“I am deeply grateful for this opportunity, and both honored and humbled by the responsibility it carries.
As I reflect on this moment, I’m reminded that none of us walks this path alone. We stand on the shoulders of those who came before us, lean on those who walk alongside us, and have a responsibility to lift those who follow.
Thankful for the mentors, colleagues, and teams who have made this journey possible
As I look ahead, I’m inspired by the opportunity to build, to serve, and to create something that meaningfully improves the lives of our patients we are so privileged to serve.
The work continues—and the best is still ahead.”
Innovative Hematology, Inc. shared a post on LinkedIn:
“Today marks Dr. Sanjay Ahuja‘s first day as Medical Director and CEO of Innovative Hematology.
As we look ahead, our focus now is clear:
to build on the strong foundation already in place, strengthen the continuity of care our patients depend on, and position IHI for thoughtful and sustainable growth.
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention